Summary of Product Characteristics
last updated on the eMC:
14/10/2010
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 14/10/2010 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 8 - MARKETING AUTHORISATION NUMBER(S)
|
| Date of revision of text on the SPC: 15-Sep-2010 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Deximune 25 mg: PL 14017/0215 (Previously PL 14017/0144)
Deximune 50 mg: PL 14017/0216 (Previously PL 14017/0145)
Deximune 100 mg: PL 14017/0217 (Previously PL 14017/0146)
|
|
Updated on 14/04/2010 and displayed until 14/10/2010
|
Reasons for adding or updating:
|
-
New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC
|
| Date of revision of text on the SPC: |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| None provided |
|